Catalyst Pharmaceuticals Inc CPRX shares are trading lower by 1.47% at $10.71. Traders and investors are watching for the company’s second-quarter earnings report, confirmed for Tuesday’s after-hours session.
According to analyst consensus estimates, Catalyst Pharmaceuticals is expected to report EPS of 17 cents on revenue of $49.21 million. The company last quarter missed EPS estimates by 14.29% and exceeded revenue estimates by 0.79% respectively.
See Also: So Should Amazon Or Alibaba Try To Acquire ContextLogic (WISH) In 2022?
According to data from Benzinga Pro, Catalyst Pharmaceuticals has a 52-week high of $11.32 and a 52-week low of $4.81.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
